Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXAGEN INC. Director's Dealing 2020

Jan 9, 2020

33644_dirs_2020-01-09_d304d3a1-03b3-479f-91dc-c86daa58c942.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2020-01-09

Reporting Person: Rocca Fortunato R. (Director, President and CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-01-09 Stock Option(right to buy) $24.19 A 155000 Acquired 2030-01-08 Stock Option(right to buy) (155000.0) Direct

Footnotes

F1: The option is exercisable as it vests. 25% of the shares subject to the option vest on January 1, 2021, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.